Althof Stanley E, Leiblum Sandra R, Chevret-Measson Marie, Hartmann Uwe, Levine Stephen B, McCabe Marita, Plaut Michael, Rodrigues Oswaldo, Wylie Kevan
Department of Urology, Case School of Medicine, Cleveland, OH, USA.
J Sex Med. 2005 Nov;2(6):793-800. doi: 10.1111/j.1743-6109.2005.00145.x.
There are limited outcome data on the efficacy of psychological interventions for male and female sexual dysfunction and the role of innovative combined treatment paradigms.
To highlight the salient psychological and interpersonal issues contributing to sexual health and dysfunction; to offer a four-tiered paradigm for understanding the evolution and maintenance of sexual symptoms; and to offer recommendations for clinical management and research.
An International Consultation assembled over 200 multidisciplinary experts from 60 countries into 17 committees. The recommendations of committee members represent state-of-the-art knowledge and opinions of experts from five continents were developed in a process over a 2-year period. Concerning the Psychological and Interpersonal Committee of Sexual Function and Dysfunction, there were nine experts from five countries.
Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation, and debate.
Medical and psychological therapies for sexual dysfunctions should address the intricate biopsychosocial influences of the patient, the partner, and the couple. The biopsychosocial model provides a compelling reason for skepticism that any single intervention (i.e., a phosphodiesterase type 5 inhibitor, supraphysiological doses of a hormone, processing of childhood victimization, marital therapy, pharmacotherapy of depression, etc.) will be sufficient for most patients or couples experiencing sexual dysfunction.
There is need for collaboration between healthcare practitioners from different disciplines in evaluation, treatment, and education issues surrounding sexual dysfunction. In many cases, neither psychotherapy alone nor medical intervention alone is sufficient for the lasting resolution of sexual problems. Assessment of male, female, and couples' sexual dysfunction should ideally include inquiry about: predisposing, precipitating, maintaining, and contextual factors. Treatment of lifelong and/or chronic dysfunction will be different from acquired or recent dysfunction. Research is needed to identify efficacious combined and/or integrated treatments for sexual dysfunction.
关于心理干预对男性和女性性功能障碍的疗效以及创新联合治疗模式的作用,现有结果数据有限。
强调导致性健康和性功能障碍的突出心理及人际问题;提供一个四层模式以理解性症状的演变和维持;并为临床管理和研究提供建议。
一次国际咨询会议召集了来自60个国家的200多名多学科专家,组成17个委员会。委员会成员的建议代表了来自五大洲专家的最新知识和意见,这是在两年时间里形成的。关于性功能与障碍心理和人际委员会,有来自五个国家的九位专家。
专家意见基于循证医学文献分级、委员会内部广泛讨论、公开报告及辩论。
性功能障碍的医学和心理治疗应解决患者、伴侣及夫妻复杂的生物心理社会影响。生物心理社会模式令人信服地质疑,对于大多数患有性功能障碍的患者或夫妻而言,任何单一干预措施(如5型磷酸二酯酶抑制剂、超生理剂量激素、处理童年受害经历、婚姻治疗、抑郁症药物治疗等)是否足够。
在围绕性功能障碍的评估、治疗和教育问题上,不同学科的医疗从业者需要开展合作。在许多情况下,单独的心理治疗或单独的医学干预都不足以持久解决性问题。对男性、女性及夫妻性功能障碍的评估理想情况下应包括询问:易患因素、促发因素、维持因素和背景因素。终身性和/或慢性性功能障碍的治疗将不同于后天性或近期性功能障碍的治疗。需要开展研究以确定针对性功能障碍的有效联合和/或综合治疗方法。